Literature DB >> 33284032

Symptomatic Retinal Microangiophaty in a Patient with Coronavirus Disease 2019 (COVID-19): Single Case Report.

Julio J Gonzalez-Lopez1, Beatriz Felix Espinar1, Cristina Ye-Zhu1.   

Abstract

Purpose: Coronavirus Disease 2019 (COVID-19) can cause conjunctivitis in up to 31.6% of patients. Additionally, retinal findings compatible with retinal microvascular ischemia have also been associated with coronavirus disease in asymptomatic patients. We describe a case of bilateral retinal changes compatible with microangiopathy occurring during the late phase of COVID-19.Case report: A 50-year-old man with bilateral pneumonia and positive polymerase chain reaction for SARS-CoV-2 developed an arcuate visual field defect in his left eye. Funduscopy revealed multiple, bilateral cotton-wool spots without haemorraghes. OCT-angiography revealed multifocal areas of retinal microvascular ischemia in the superficial plexus, the largest of which corresponded to the arcuate scotoma observed in the automated perimetry.
Conclusion: Visual field defects due to retinal microangiopathy can occur during the late phase of COVID-19. Vascular changes observed in the retina may mimic what may be happening in other, less-accessible organs.

Entities:  

Keywords:  Communicable diseases; Covid-19; ophthalmology; retina; uveitis

Year:  2020        PMID: 33284032     DOI: 10.1080/09273948.2020.1852260

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  6 in total

1.  Retinopathy and Systemic Disease Morbidity in Severe COVID-19.

Authors:  Jessica G Shantha; Sara C Auld; Casey Anthony; Laura Ward; Max W Adelman; Cheryl L Maier; Kenneth W Price; Jesse T Jacob; Tolulope Fashina; Casey Randleman; Lucy T Xu; Joshua Barnett; Ofer Sadan; Prem A Kandiah; Jay B Varkey; Colleen S Kraft; Nadine Rouphael; Susanne Linderman; Rafi Ahmed; Carolyn Drews-Botsch; Jesse J Waggoner; Max Weinmann; David J Murphy; Steven Yeh
Journal:  Ocul Immunol Inflamm       Date:  2021-08-31       Impact factor: 3.728

Review 2.  Pre-existing diabetic retinopathy as a prognostic factor for COVID-19 outcomes amongst people with diabetes: A systematic review.

Authors:  Isabel Boden; Miguel O Bernabeu; Baljean Dhillon; David A Dorward; Ian MacCormick; Roly Megaw; Claire Tochel
Journal:  Diabetes Res Clin Pract       Date:  2022-04-05       Impact factor: 8.180

3.  Late retinal and optic nerve vascular complications due to COVID-19 in young individuals.

Authors:  Jaime Larrea; Eva Villota-Deleu; Beatriz Fernández-Vega; Álvaro Fernández-Vega Sanz
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-29

4.  Acute macular neuroretinopathy as the first stage of SARS-CoV-2 infection.

Authors:  Vittorio Capuano; Paolo Forte; Riccardo Sacconi; Alexandra Miere; Carl-Joe Mehanna; Caterina Barone; Francesco Bandello; Eric H Souied; Giuseppe Querques
Journal:  Eur J Ophthalmol       Date:  2022-03-31       Impact factor: 2.597

Review 5.  Use of Imaging Technology to Assess the Effect of COVID-19 on Retinal Tissues: A Systematic Review.

Authors:  Orlaith E McGrath; Tariq M Aslam
Journal:  Ophthalmol Ther       Date:  2022-04-29

Review 6.  COVID-19-Related Retinal Micro-vasculopathy - A Review of Current Evidence.

Authors:  Kelvin Yc Teo; Alessandro Invernizzi; Giovanni Staurenghi; Chui Ming Gemmy Cheung
Journal:  Am J Ophthalmol       Date:  2021-09-26       Impact factor: 5.258

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.